StockData
Annovis Bio, Inc. logo

Annovis Bio, Inc. (ANVS) stock

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.84+0.10 (+13.16%)

Close on Nov 18, 2026Market cap $35.83MP/E –Yield –

Annovis Bio free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Annovis Bio

Annovis Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Annovis Bio figures

See a number that looks wrong?